Targeting NF-κB in Waldenstrom macroglobulinemia

The nuclear factor-κB (NF-κB) path-way has been implicated in tumor B-cell survival, growth, and resistance to therapy. Because tumor cells overcome single-agent antitumor activity, we hypothesized that combination of agents that target differentially NF-κB pathway will induce significant cytotoxici...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Leleu, Xavier, Eeckhoute, Jérôme, Jia, Xiaoying, Roccaro, Aldo M., Moreau, Anne-Sophie, Farag, Mena, Sacco, Antonio, Ngo, Hai T., Runnels, Judith, Melhem, Molly R., Burwick, Nicolas, Azab, Abdelkareem, Azab, Feda, Hunter, Zachary, Hatjiharissi, Evdoxia, Carrasco, Daniel R., Treon, Steven P., Witzig, Thomas E., Hideshima, Teru, Brown, Myles, Anderson, Kenneth C., Ghobrial, Irene M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2008
Soggetti:
Neoplasia
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2384134/
https://ncbi.nlm.nih.gov/pubmed/18334673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-09-115170
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi